EN DE
STOCK COMPARISON

Bora Pharmaceuticals vs Jiangsu Hengrui Medicine Co: Fair Value & Quality

Both stocks run through our valuation models. Here is how Bora Pharmaceuticals (6472) and Jiangsu Hengrui Medicine Co (600276) compare, as of Aug 10, 2026.

As of Aug 10, 2026, Fair Value Calculator sees Bora Pharmaceuticals as the less overvalued of the two: Bora Pharmaceuticals trades at TWD 418 versus a fair value of TWD 363 (-13%), while Jiangsu Hengrui Medicine Co trades at ¥54.62 versus ¥25.94 (-53%).
Bora Pharmaceuticals
6472.TW · TWD · Healthcare
-13%
upside to fair value
overvalued
PriceTWD 418
Fair ValueTWD 363
Quality39/100
Jiangsu Hengrui Medicine Co
600276.SHG · CNY · Health Care
-53%
upside to fair value
overvalued
Price¥54.62
Fair Value¥25.94
Quality66/100

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Bora PharmaceuticalsJiangsu Hengrui Medicine Co
Valuation
12.1×P/E (TTM)43.6×
2.79×P/S (TTM)10.84×
3.36×P/B5.76×
14.9×EV/EBITDA33.0×
—PEG0.93×
2.6%Dividend yield0.4%
TWD 10.00Dividend per share¥0.20
Profitability
9%Net margin25%
10%Operating margin32%
11%Return on equity15%
4%Return on assets9%
Growth
-11%Revenue growth (YoY)13%
21.9%Avg. growth/yr (3Y)13.9%
60.2%Avg. growth/yr (5Y)2.5%
Balance & size
0.77×Debt / equity—
$2BMarket cap$52B
mixedGrowth qualityhealthy

Bora Pharmaceuticals leads: 7 to 5 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Bora Pharmaceuticalsof which business quality 44 · market factors 32 Jiangsu Hengrui Medicine Coof which business quality 68 · market factors 46
ProfitabilityMargins and returns on capital today
48
63
Quality GrowthAre margins and returns improving?
29
41
CashflowEarnings quality: real cash, not paper profit
72
82
Fin. StrengthBalance sheet, leverage, solvency risk
46
100
InvestmentDisciplined investing over empire-building
28
27
Low VolatilityCalm price path (market factor)
66
78
MomentumPrice trend over the last 3–12 months (market factor)
22
35
52W MomentumDistance to the 52-week high (market factor)
9
29
Net IssuanceBuybacks instead of dilution
17
64

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

Bora Pharmaceuticals

DCF ModelsTWD 730
Earnings-BasedTWD 820
Dividend DiscountTWD 200
MultiplesTWD 377
Asset-BasedTWD 80.96
Growth DCFTWD 658
Economic ProfitTWD 213
Growth EarningsTWD 1,056

11 of 26 models see the stock below the current price.

Jiangsu Hengrui Medicine Co

DCF Models¥37.78
Earnings-Based¥21.29
Dividend Discount¥3.82
Multiples¥23.65
Asset-Based¥6.44
Growth DCF¥39.88
Economic Profit¥18.21
Growth Earnings¥30.99

26 of 26 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Bora Pharmaceuticals
Bear TWD 272Fair Value TWD 363Bull TWD 883
TWD 418 = current price (white tick)
Jiangsu Hengrui Medicine Co
Bear ¥19.95Fair Value ¥25.94Bull ¥40.28
¥54.62 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Bora Pharmaceuticals · Healthcare

Quality score39 · bottom 25%
Fair value upside-13% · above median

Jiangsu Hengrui Medicine Co · Health Care

Quality score66 · Top 25%
Fair value upside-53% · below median

Bottom line

As of Aug 10, 2026, Fair Value Calculator sees Bora Pharmaceuticals as the less overvalued of the two: Bora Pharmaceuticals trades at TWD 418 versus a fair value of TWD 363 (-13%), while Jiangsu Hengrui Medicine Co trades at ¥54.62 versus ¥25.94 (-53%).

Jiangsu Hengrui Medicine Co has the higher quality score (66/100).

See the full analysis →
Bora Pharmaceuticals · Jiangsu Hengrui Medicine Co

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Related to Bora Pharmaceuticals

Alphabet Inc Class C vs Verizon CommunicationsAlphabet Inc Class C vs At&tAlphabet Inc Class C vs NetEaseAmazon.com vs Toyota Motor Corporation

Related to Jiangsu Hengrui Medicine Co

Eli Lilly and vs UnitedHealth GroupJohnson & Johnson vs UnitedHealth GroupAbbVie vs UnitedHealth GroupUnitedHealth Group vs Merck & Company
Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.